Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS | MicrobiomeTrials← Back to trialsNCT06796426
Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS
AVAILABLEEXPANDED_ACCESS
Trial Details
Locations- Arrowhead Pharmaceuticals, Inc., Pasadena, California, United States
Other microbiome trials you might be interested in
Familial Chylomicronemia
The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 (plozasiran) in adult participants with…
Boca Raton, United StatesCompleted Apr 29, 2024
Type 1 Hyperlipoprotenemia
Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the b…
Dallas, United StatesEst. completion Aug 1, 2027